Kuano provides innovative quantum and AI solutions for drug discovery and design.
Kuano has raised $2.2M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
Kuano's investors include Innovate UK, Creative Destruction Lab (CDL), ACF Investors, Ascension Ventures, Mercia Ventures.
Kuano is headquartered in London, United Kingdom.
Kuano provides innovative quantum and AI solutions for drug discovery and design.
Kuano is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kuano — Funding & Investors." VCBacked, September 12, 2023, https://www.vcbacked.co/company/kuano. Accessed July 25, 2026.
VCBacked. (2023). Kuano — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/kuano
{{cite web |title=Kuano — Funding & Investors |url=https://www.vcbacked.co/company/kuano |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated